Zhengye Biotechnology Holding (ZYBT) Cash Flow: Operating & Free Cash Flow

Zhengye Biotechnology Holding Cash Flow Statement Analysis

Values in millions CNY

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Zhengye Biotechnology Holding Limited (ZYBT) - Annual data in millions CNY
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Dec 2025	Jun 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Operating Activities
Net Income	-82.97	13.47	13.47	37.51	55.74	46.47
Depreciation & Amortization	25.96	24.16	24.16	23.91	18.80	16.01
Deferred Income Tax	11.10	0.92	0.92	0.54	-1.09	-0.36
Change in Working Capital	44.83	-0.98	-0.98	-20.28	-66.82	-33.71
Change in Accounts Receivable	61.41	11.31	12.59	39.35	-47.38	-40.68
Change in Inventory	6.25	-5.88	-5.88	-12.90	-12.33	-12.34
Change in Accounts Payable	-3.36	-0.40	-1.03	-43.51	-9.67	18.11
Change in Other Working Capital	-19.47	-6.00	-9.35	-2.12	2.56	0.00
Other Operating Activities	14.42	3.47	4.39	7.04	10.70	0.00
Net Cash from Operating Activities	13.33	41.05	41.05	48.18	17.34	31.81
Investing Activities
Capital Expenditures	-12.63	-27.77	-27.77	-11.60	-27.33	-26.40
Purchases of Investments	0.00	0.00	-	-1.22	0.00	0.00
Sales/Maturities of Investments	0.00	0.00	-14.19	-4.20	0.00	-7.34
Other Investing Activities	-11.62	-14.08	-	-3.15	0.00	-7.21
Net Cash from Investing Activities	-12.63	-27.67	-27.67	-11.77	-27.33	-26.27
Financing Activities
Debt Repayment	-12.09	-2.74	-92.86	-54.89	34.88	-22.00
Common Stock Issued	43.08	0.00	-	0.00	0.00	0.00
Dividends Paid	0.00	-16.02	-16.02	-39.45	-21.43	-11.05
Other Financing Activities	1.32	-3.37	-3.37	-4.50	0.00	0.00
Net Cash from Financing Activities	32.31	-22.13	-22.13	-18.98	13.46	-3.05
Summary
Effect of Forex Changes on Cash	-1.29	0.17	0.17	0.00	0.00	0.00
Net Change in Cash	31.73	-8.58	-8.58	17.44	3.46	2.49
Cash at Beginning of Period	18.61	27.19	27.19	9.75	6.28	3.80
Cash at End of Period	50.33	18.61	18.61	27.19	9.75	6.28
Free Cash Flow	0.70	13.27	13.27	36.58	-9.99	5.41
Supplemental Disclosures
Interest Paid	-	-	3.99	4.42	2.84	1.05
Income Taxes Paid	-	-	0.12	10.49	8.48	6.99

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Zhengye Biotechnology Holding Cash Flow

What is Zhengye Biotechnology Holding's free cash flow?

Zhengye Biotechnology Holding generated free cash flow of CNY 703.00K in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of CNY 13.33M minus CNY 12.63M of capital expenditures. That was down 94.7% from CNY 13.27M a year earlier. Free cash flow equaled 0.6% of revenue.

How much does Zhengye Biotechnology Holding spend on capital expenditures?

Zhengye Biotechnology Holding spent CNY 12.63M on capital expenditures in fiscal 2025, compared with CNY 27.77M a year earlier. That equals 94.7% of operating cash flow.

Does Zhengye Biotechnology Holding pay dividends or buy back shares?

Zhengye Biotechnology Holding's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition